Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis.
about
H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expressionBlockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.Computational identification of epigenetically regulated lncRNAs and their associated genes based on integrating genomic data.Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.Genomic imprinting: implications for human disease.The new field of epigenomics: implications for cancer and other common disease research.The imprinted gene PEG3 inhibits Wnt signaling and regulates glioma growthImprinted genes as potential genetic and epigenetic toxicologic targetsInsulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.Imprinting methylation errors in ART.Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma.Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogrammingComparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumourStratification of Wilms tumor by genetic and epigenetic analysisISWI contributes to ArsI insulator function in development of the sea urchinGametes and embryo epigenetic reprogramming affect developmental outcome: implication for assisted reproductive technologies.Decreased expression of p57(KIP2)mRNA in human bladder cancer.Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures.Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications.Epigenetic drugs for cancer treatment and prevention: mechanisms of action.Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675Tumor Phenotype and Gene Expression During Early Mammary Tumor Development in Offspring Exposed to Alcohol In Utero.Constitutional and somatic methylation status of DMRH19 and KvDMR in Wilms tumor patients.Long non-coding RNA-H19 antagonism protects against renal fibrosis.Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.Mosaicism for GNAS methylation defects associated with pseudohypoparathyroidism type 1B arose in early post-zygotic phases.Critical effects of long non-coding RNA on fibrosis diseases.DNA methylation errors in imprinting disorders and assisted reproductive technology.Transcriptional regulation and biological significance of the insulin like growth factor II gene.Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor.Global demethylation in loss of imprinting subtype of Wilms tumor.Epigenetic Mechanisms in Cancer Formation and ProgressionFrequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer
P2860
Q24682023-22AF0338-5071-4AE1-841E-592AB9B50750Q24798922-D3DD71FB-2388-4AFA-BF08-47FA7967E3FFQ30885763-2130E67A-EAF1-4B30-A165-A17A8A164B58Q33325473-77BFAFC1-37EE-4C51-8D3B-929C99EBD02DQ33541538-BABD3474-2FBE-447D-BF6D-6C13DCE02903Q33698033-8C71ED5F-BBF7-4DA9-BB17-D1F2CCE2487DQ33707208-C758F86C-6D0D-46E6-BD59-B6D761A11565Q33852775-46068FF3-F013-44F7-AE3C-D211647153E7Q33858986-9CCF4C9F-1332-4EA4-8585-582E618C1206Q34277727-3906D7F8-F1E9-41A0-9EDF-2F862A730817Q35076810-AAD35F5B-84B5-48D0-84D0-23C25337A2E1Q35130964-B8A1F4FA-C6B2-4CAA-881A-D7012D698FB1Q35163343-FDE5A752-9FFE-4974-8250-6732827566E3Q35987087-0940D722-66DB-45CD-AC78-B84B20393EFDQ36215754-13C741E4-2E94-47A2-B2AE-8D54319D72D5Q36251483-5547D9B3-2EC5-4253-94DB-E5DC7BCEE787Q36621880-C04F9126-D1C3-42E2-A268-329A43BDA983Q36899265-2397D3AA-C338-4C9C-A8E0-DE42019C0D87Q37149909-80A7E04A-5C49-4244-B12A-C0C6F7FE628EQ38472433-53880609-EED9-4978-A30B-3E8FB975DFB8Q39030277-442C757E-1D2E-427D-B8A0-761DDFFA3069Q39636088-9074819B-001C-4A38-B58D-3B4EE77F89DEQ41868632-4854D1F6-704A-43D7-9439-328818A77234Q42118265-B88BAB59-239B-40DE-85E0-17255DAFE60AQ42277975-1F28DC85-B65A-4129-BF4C-2C386D32A282Q47924478-CA4D7333-57E2-4859-8322-3F7EC6A2A084Q49895247-AC32606D-A831-4C8C-8B54-0353618A69FAQ49922983-FF6BA2AF-C287-4DDA-A3D7-2690119D5707Q51380383-8AC01322-09A2-471A-ADB4-FF78B822308AQ52180058-F9EACE51-5A1E-476D-B173-FDC43A33BB1AQ52181418-608D6183-B4A2-4CB5-83E5-36117D1CDDB5Q53765119-D741895E-142B-42FA-BA76-5EBD122FC568Q54287191-BBDED457-48B4-4E7D-A4BE-44897911B6F8Q57570317-E030F896-794B-4F42-B0D1-614CFE1ED864Q58134450-C0AF0865-4F29-4CC6-827A-B02C506AF89C
P2860
Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Epigenetic changes at the insu ...... event in Wilms tumorigenesis.
@ast
Epigenetic changes at the insu ...... event in Wilms tumorigenesis.
@en
type
label
Epigenetic changes at the insu ...... event in Wilms tumorigenesis.
@ast
Epigenetic changes at the insu ...... event in Wilms tumorigenesis.
@en
prefLabel
Epigenetic changes at the insu ...... event in Wilms tumorigenesis.
@ast
Epigenetic changes at the insu ...... event in Wilms tumorigenesis.
@en
P2093
P2860
P356
P1476
Epigenetic changes at the insu ...... y event in Wilms tumorigenesis
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.10.5367
P407
P577
1997-05-01T00:00:00Z